Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association 2023-11-06 09:00
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy 2023-11-05 08:00
The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan 2023-11-03 12:10
ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM 2023-11-03 09:15
ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting 2023-11-03 09:10
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients. 2023-11-03 05:15
Complete Genomics and Basepair™ Announce Technology Integration Partnership 2023-11-02 21:00
Boryung Successfully Concludes 'Humans In Space Symposium' at 2023 ASCEND in Las Vegas 2023-11-02 20:00
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN) 2023-11-02 20:00
Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023 2023-11-02 20:00
Chipscreen's New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis 2023-11-02 15:58
Precision, Effectiveness, and Intelligence: Explore the Latest Trend of Healthcare and Medical Equipment Industry at 134th Canton Fair 2023-11-02 08:00
Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine 2023-11-02 00:00
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023 2023-11-01 21:08
Jolly Good Inc. Establishes North American Subsidiary: Joint Development of Medical VR for "Apple Vision Pro" with U.S. Experts 2023-11-01 21:00
I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023 2023-11-01 20:00
Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T 2023-11-01 16:23
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S. 2023-10-31 21:44
Lunit Joins as an Associate Partner with the World Economic Forum 2023-10-31 21:00
1 39 40 41 42 43 773